Drug Type AAV based gene therapy |
Synonyms IKC 113, IKC113 |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | GB | Ikarovec Ltd.Startup | 01 Jun 2022 |